Novel Therapeutic Rationale for Targeting HDAC1 and PIM2 in Multiple Myeloma

被引：0
|
作者：
Harada, Takeshi [1 ]
Oda, Asuka [1 ]
Ohguchi, Hiroto [2 ]
Grondin, Yohann [3 ]
Tenshin, Hirofumi [4 ]
Hiasa, Masahiro [4 ]
Teramachi, Jumpei [5 ]
Oura, Masahiro [1 ]
Sogabe, Kimiko [1 ]
Fujii, Shiro [1 ]
Nakamura, Shingen [1 ]
Miki, Hirokazu [6 ]
Kagawa, Kumiko [1 ]
Ozaki, Shuji [7 ]
Hideshima, Teru [8 ]
Anderson, Kenneth C. [8 ]
Abe, Masahiro [1 ]
机构：
[1] Tokushima Univ, Inst Biomed Sci, Dept Hematol Endocrinol & Metab, Grad Sch, Tokushima, Japan
[2] Kumamoto Univ, Div Dis Epigenet, IRDA, Kumamoto, Japan
[3] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA USA
[4] Tokushima Univ, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, Tokushima, Japan
[5] Tokushima Univ, Inst Biomed Sci, Dept Tissue Regenerat, Grad Sch, Tokushima, Japan
[6] Tokushima Univ Hosp, Div Transfus Med & Cell Therapy, Tokushima, Japan
[7] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan
[8] Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3111
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All
    Stubbs, Matthew C.
    Kim, Won-Il
    Davis, Tina
    Qi, Jun
    Bradner, James
    Kung, Andrew L.
    Armstrong, Scott A.
    BLOOD, 2010, 116 (21) : 1194 - 1194
  • [32] The rationale for the dual targeting of RSK2 and AKT in multiple myeloma
    Kuroda, Junya
    Tsukamoto, Taku
    Horinaka, Mano
    Sakai, Toshiyuki
    CANCER SCIENCE, 2023, 114 : 1250 - 1250
  • [33] HDAC1 and HDAC2 are Differentially Expressed in Endometriosis
    Maricarmen Colón-Díaz
    Perla Báez-Vega
    Miosotis García
    Abigail Ruiz
    Janice B. Monteiro
    Jessica Fourquet
    Manuel Bayona
    Carolina Alvarez-Garriga
    Alexandra Achille
    Edward Seto
    Idhaliz Flores
    Reproductive Sciences, 2012, 19 : 483 - 492
  • [34] Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
    Prabhala, R. H.
    Fulciniti, M.
    Pelluru, D.
    Rashid, N.
    Nigroiu, A.
    Nanjappa, P.
    Pai, C.
    Lee, S.
    Prabhala, N. S.
    Bandi, R. L.
    Smith, R.
    Lazo-Kallanian, S. B.
    Valet, S.
    Raje, N.
    Gold, J. S.
    Richardson, P. G.
    Daley, J. F.
    Anderson, K. C.
    Ettenberg, S. A.
    Di Padova, F.
    Munshi, N. C.
    LEUKEMIA, 2016, 30 (02) : 379 - 389
  • [35] Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
    R H Prabhala
    M Fulciniti
    D Pelluru
    N Rashid
    A Nigroiu
    P Nanjappa
    C Pai
    S Lee
    N S Prabhala
    R L Bandi
    R Smith
    S B Lazo-Kallanian
    S Valet
    N Raje
    J S Gold
    P G Richardson
    J F Daley
    K C Anderson
    S A Ettenberg
    F Di Padova
    N C Munshi
    Leukemia, 2016, 30 : 379 - 389
  • [36] The role of PIM1/PIM2 kinases in tumors of the male reproductive system
    Manuel Pedro Jiménez-García
    Antonio Lucena-Cacace
    María José Robles-Frías
    Maja Narlik-Grassow
    Carmen Blanco-Aparicio
    Amancio Carnero
    Scientific Reports, 6
  • [37] HDAC1 and HDAC2 are Differentially Expressed in Endometriosis
    Colon-Diaz, Maricarmen
    Baez-Vega, Perla
    Garcia, Miosotis
    Ruiz, Abigail
    Monteiro, Janice B.
    Fourquet, Jessica
    Bayona, Manuel
    Alvarez-Garriga, Carolina
    Achille, Alexandra
    Seto, Edward
    Flores, Idhaliz
    REPRODUCTIVE SCIENCES, 2012, 19 (05) : 483 - 492
  • [38] Targeting IRE1α-XBP1 Pathway Is a Novel Therapeutic Strategy In Multiple Myeloma
    Mimura, Naoya
    Hideshima, Teru
    Gorgun, Gullu
    Cirstea, Diana
    Santo, Loredana
    Hu, Yiguo
    Fabre, Claire
    Blumenthal, Martina
    Tam, Victor
    Kertesz, Nathalie L.
    Zeng, Qingping
    Patterson, John B.
    Munshi, Nikhil C.
    Richardson, Paul
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (21) : 1659 - 1659
  • [39] PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
    Gomez-Abad, Cristina
    Pisonero, Helena
    Blanco-Aparicio, Carmen
    Roncador, Giovanna
    Gonzalez-Menchen, Alberto
    Martinez-Climent, Jose A.
    Mata, Eva
    Elena Rodriguez, Maria
    Munoz-Gonzalez, Guillermo
    Sanchez-Beato, Margarita
    Leal, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    BLOOD, 2011, 118 (20) : 5517 - 5527
  • [40] Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly
    Charles A. S. Banks
    Sayem Miah
    Mark K. Adams
    Cassandra G. Eubanks
    Janet L. Thornton
    Laurence Florens
    Michael P. Washburn
    Scientific Reports, 8
12345